TABLE 3.
Self‐comparison of ADL scores in AD and aMCI patients before and after hyperbaric oxygen treatment
| AD | aMCI | |||
|---|---|---|---|---|
| Time | Mean ± SD | P value | Mean ± SD | P value |
| Baseline | 38.19 ± 13.90 | – | 21.00 ± 1.26 | – |
| 1‐month follow‐up | 36.40 ± 13.89 | 0.008 * | 21.00 ± 1.41 | 1.000 |
| 3‐month follow‐up | 35.07 ± 14.14 | 0.004 * | 21.18 ± 1.78 | 0.655 |
| 6‐month follow‐up | 38.12 ± 14.21 | 0.678 | 20.73 ± 0.90 | 0.180 |
Data of ADL scale in AD and aMCI patients were analyzed by Wilcoxon signed‐rank test.
*
P < 0.05. Sample size: n = 42 in AD patients (n = 40 at 6‐month follow‐up); n = 11 in aMCI patients. The P values of 1‐, 3‐, and 6‐month follow‐up were compared with the baseline level.
Abbreviations: AD, Alzheimer's disease: ADL, Activities of Daily Living; aMCI, amnestic mild cognitive impairment; SD, standard deviation